These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 9554806

  • 1. Pharmacologic profile of TA-606, a novel angiotensin II-receptor antagonist in the rat.
    Hashimoto Y, Ohashi R, Kurosawa Y, Minami K, Kaji H, Hayashida K, Narita H, Murata S.
    J Cardiovasc Pharmacol; 1998 Apr; 31(4):568-75. PubMed ID: 9554806
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. In vivo pharmacologic profile of SK-1080, an orally active nonpeptide AT1-receptor antagonist.
    Lee BH, Seo HW, Kwon KJ, Yoo SE, Shin HS.
    J Cardiovasc Pharmacol; 1999 Mar; 33(3):375-82. PubMed ID: 10069671
    [Abstract] [Full Text] [Related]

  • 5. Comparative cardiovascular effects of the angiotensin II type 1 receptor antagonists ZD 7155 and losartan in the rat.
    Junggren IL, Zhao X, Sun X, Hedner T.
    J Pharm Pharmacol; 1996 Aug; 48(8):829-33. PubMed ID: 8887734
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of SR 47436 (BMS-186295), a non-peptide angiotensin AT1 receptor antagonist in hypertensive rat models.
    Lacour C, Canals F, Galindo G, Cazaubon C, Segondy D, Nisato D.
    Eur J Pharmacol; 1994 Nov 03; 264(3):307-16. PubMed ID: 7698170
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pharmacological profile of ME3221, a novel angiotensin II receptor antagonist.
    Nagura J, Yasuda S, Fujishima K, Yamamoto M, Hui C, Kawano K, Katano K, Ogino H, Hachisu M, Konno F.
    Eur J Pharmacol; 1995 Feb 14; 274(1-3):201-11. PubMed ID: 7768273
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4- yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug, (+/-)-1-(cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5- yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (TCV-116).
    Shibouta Y, Inada Y, Ojima M, Wada T, Noda M, Sanada T, Kubo K, Kohara Y, Naka T, Nishikawa K.
    J Pharmacol Exp Ther; 1993 Jul 14; 266(1):114-20. PubMed ID: 8331552
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A novel angiotensin II-receptor antagonist, 606A, induces regression of cardiac hypertrophy, augments endothelium-dependent relaxation and improves renal function in stroke-prone spontaneously hypertensive rats.
    Hashimoto Y, Kurosawa Y, Minami K, Fushimi K, Narita H.
    Jpn J Pharmacol; 1998 Feb 14; 76(2):185-92. PubMed ID: 9541281
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of the new angiotensin II type 1 receptor antagonist KRH-594 on several types of experimental hypertension.
    Inada Y, Murakami M, Kaido K, Nakao K.
    Arzneimittelforschung; 1999 Jan 14; 49(1):13-21. PubMed ID: 10028373
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. In vivo pharmacological characterization of UP 269-6, a novel nonpeptide angiotensin II receptor antagonist.
    Cazes M, Provost D, Versigny A, Cloarec A.
    Eur J Pharmacol; 1995 Sep 15; 284(1-2):157-70. PubMed ID: 8549620
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.